Learn More
Medchemexpress LLC TBOPP | 1996629-79-8 | 99.6% | 490.49 | C24H21F3N2O4S | 50MG

Supplier: Medchemexpress LLC HY12471150MG
TBOPP is a small-molecule research reagent that selectively inhibits DOCK1. It blocks DOCK1-mediated Rac activation with an IC50 of 8.4 μM and binds the DOCK1 DHR-2 domain with a Kd of 7.1 μM. TBOPP has shown anti-tumor activity in preclinical studies and is provided as a high-purity compound with available powder and DMSO solution formats for biochemical and cellular experiments.
- High purity suitable for research applications.
- Selective inhibitor of DOCK1 with IC50 8.4 μM and Kd 7.1 μM.
- Demonstrated anti-tumor activity in preclinical models.
- Available as powder and as a DMSO solution for flexible dosing.
- Comes with supporting documentation such as datasheet, COA, and SDS.
- Stable under recommended cold storage for long-term preservation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.